CD40 and ovarian cancer: We have previously demonstrated, for example, the use of low-dose irradiation to reverse immune desertification combined with immune checkpoint blockade, CD40 agonist antibody, and cyclophosphamide to reprogram endogenous adaptive and innate immunity for improved control of ovarian cancer (ID8).38